This article is a correction to:
Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects
Ting-Jung Lin1,2†
Kuang-Chao Cheng1,2†
Luo-Yun Wu1,2†
Wei-Yu Lai2,3
Thai-Yen Ling4,5
Yung-Che Kuo3*
Yen-Hua Huang2,3,6,7,8,9,10,11*- 1School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 2Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 3TMU Research Center for Cell Therapy and Regeneration Medicine, Taipei Medical University, Taipei, Taiwan
- 4Department and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
- 5Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan
- 6International Ph.D. Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 7Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 8Center for Reproductive Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
- 9TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan
- 10Comprehensive Cancer Center of Taipei Medical University, Taipei, Taiwan
- 11PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
A Corrigendum on
Potential of cellular therapy for ALS: current strategies and future prospects
by Lin T-J, Cheng K-C, Wu L-Y, Lai W-Y, Ling T-Y, Kuo Y-C and Huang Y-H (2022). Front. Cell Dev. Biol. 10:851613. doi: 10.3389/fcell.2022.851613
In the published article, an author name was incorrectly written as “Guang-Chao Cheng”. The correct spelling is “Kuang-Chao Cheng”. This has been corrected and thereby the citation and author initials in the author contribution section have been corrected.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ALS, mesenchymal stem cell, motor neuron degeneration, precision medicine, cellular therapy
Citation: Lin T-J, Cheng K-C, Wu L-Y, Lai W-Y, Ling T-Y, Kuo Y-C and Huang Y-H (2023) Corrigendum: Potential of cellular therapy for ALS: current strategies and future prospects. Front. Cell Dev. Biol. 11:1292681. doi: 10.3389/fcell.2023.1292681
Received: 11 September 2023; Accepted: 12 September 2023;
Published: 19 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Lin, Cheng, Wu, Lai, Ling, Kuo and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yen-Hua Huang, cml0YTEyMDRAdG11LmVkdS50dw==; Yung-Che Kuo, czAzMjcxQHRtdS5lZHUudHc=
†These authors contributed equally to this work and shared first authorship